Recent

% | $
Quotes you view appear here for quick access.

PBF Energy Inc. Message Board

oracletrades 14 posts  |  Last Activity: 18 hours ago Member since: Dec 25, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Chart shows clear bottom on very large volume.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Aggressive growth - Recently acquired HealthPath and MedX with more to be announced

    New management is very strong, capable and with strong healthcare relationships. New CEO and President already grew $1.3 Billion sales in previous company.

    Revenues set to explode again in 2015.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • oracletrades oracletrades Jul 24, 2015 2:52 PM Flag

    Great pick joinerbobslide

    Buyers are doing amazing job at sucking every share out of the market without raising price . . . YET!!

    Hang on, this one is getting ready to blast off any day

    Sentiment: Strong Buy

  • Chart shows buying just beginning to accelerate.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Aggressive growth - Recently acquired HealthPath and MedX with more to be announced

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Chart shows turnaround with volume building and buying just beginning to accelerate.

    Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • oracletrades oracletrades Jul 13, 2015 4:11 PM Flag

    Mid August coming in only one month.

    The showcase is going to blow a lot of minds in big industry and generate tremendous licensing revenues

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million

    Total market cap today at $0.01 per share equals less than $2 million.

    At only 10X revenues shares should be selling at $.45 today.

    Revenues set to explode again in 2015.

    New management that is very strong, capable and with strong healthcare relationships.

    Expect big runway of new FDA approved early detection diagnostics for heart and cancer.

    Small investment has potential for huge gains this year.

    Keep MHCC in your portfolio and watch closely for frequent news of big changes

    MHCC 12 month price target - $1.25

    Sentiment: Strong Buy

  • Noel Mijares, Millennium's incoming CEO was just quoted, “There are a host of opportunities to capitalize upon that will undoubtedly place Millennium at the forefront of the industry. To start, I plan to work to transform Millennium from a distributor of medical devices to a technology-based company. This endeavor will include acquiring companies that can immediately contribute to this process."

    Expect big news within days that Millennium is back on high growth curve. Mijares is a serious and well known-player in healthcare.

    With shares having fallen to under a nickel, Millennium Healthcare has potential for enormous percentage returns.

    Now is the perfect time to be buying while the pack is discouraged and selling.

    Expect shares to be significantly higher in days and weeks as Noel Mijares and new management announce multiple major turnaround events.

    12 month target - $1.25

    Sentiment: Strong Buy

  • BioLargo’s (BLGO) AOS filter has been repeatedly validated by researchers at the University of Alberta to decontaminate and disinfect water 100 times better, 10 times faster, and at 1/20th the cost of closest competing technology.

    BioLargo has been invited to be an NSERC chair member to help decontaminate massive tailings ponds in Canada.

    BioLargo sits on this chair along with Suncor, Syncrude, Shell, Canadian Natural Resources, Total, Epcor, Alberta Innovates, Alberta Environment and the University of Alberta.

    The AOS Filter is the biggest breakthrough in water treatment in history and will be showcased this August to major industry executives.

    The showcase will demonstrate the unprecedented results of the AOS Filter and the data the industry is looking for and will explode share prices.

    Walter Schindler just joined BioLargo as a key strategic advisor.

    When the story leaks out shares will explode. Shares are just starting to move and are a steal at anything under $1.00

    12 month price target $3
    24 month price target $12

    Sentiment: Strong Buy

  • BioLargo’s (BLGO) AOS filter has been repeatedly validated by researchers at the University of Alberta to decontaminate and disinfect water 100 times better, 10 times faster, and at 1/20th the cost of closest competing technology.

    BioLargo has been invited to be an NSERC chair member to help decontaminate massive tailings ponds in Canada.

    BioLargo sits on this chair along with Suncor, Syncrude, Shell, Canadian Natural Resources, Total, Epcor, Alberta Innovates, Alberta Environment and the University of Alberta.

    The AOS Filter is the biggest breakthrough in water treatment in history and will be showcased this August to major industry executives.

    The showcase will demonstrate the unprecedented results of the AOS Filter and the data the industry is looking for and will explode share prices.

    Walter Schindler just joined BioLargo as a key strategic advisor.

    When the story leaks out shares will explode. Shares are just starting to move up and are a steal at anything under $1.00

    12 month price target $3
    24 month price target $12

    Sentiment: Strong Buy

  • BioLargo’s AOS filter has been repeatedly validated by researchers at the University of Alberta to decontaminate and disinfect water 100 times better, 10 times faster, and at 1/20th the cost of closest competing technology.

    BioLargo has been invited to be an NSERC chair member to help decontaminate massive tailings ponds in Canada.

    BioLargo sits on this chair along with Suncor, Syncrude, Shell, Canadian Natural Resources, Total, Epcor, Alberta Innovates, Alberta Environment and the University of Alberta.

    The AOS Filter is the biggest breakthrough in water treatment in history and will be showcased this August to major industry executives.

    The showcase will demonstrate the unprecedented results of the AOS Filter and the data the industry is looking for and will explode share prices.

    Walter Schindler just joined BioLargo as a key strategic advisor.

    Shares are a steal at anything under $1.00

    12 month price target $3
    24 month price target $20

    Sentiment: Strong Buy

  • BioLargo (BLGO) and Lockheed (LMT) have proven and game changing technologies to help create abundant water for everyone.

    BioLargo’s breakthrough AOS Filter has been proven to decontaminate and disinfect water at unprecedented levels and speeds and cost 1/20th of the closest competing technology.

    The AOS Filter is showcasing this August at the University of Alberta to huge industry leaders and is extremely close to commercialization while Lockheed’s Graphene Filter is about 3 to 5 years away.

    To read report, copy and paste: Desalination Industry Screams for Cost Cutting Innovation: Lockheed And BioLargo Hold Key Technologies

    BioLargo is Strong Buy with $3.00 12-month Price Target and significantly higher in coming years.

    Sentiment: Strong Buy

  • Reply to

    SELLERS CONTINUE TO OVERWHELM UNSUSPECTING BUYERS

    by racavalli May 14, 2015 2:41 PM
    oracletrades oracletrades May 15, 2015 7:46 PM Flag

    The company just increased their authorized number of shares from 200 million to 350 million and have turned on the printing presses.

    These shares have no end to them and the company is DUMPING them on the market and burying buyers so there is no way they can ever make money in this stock.

    Buyers will wait to buy until after Sartorio, Amadola and Urbano are thrown out. These guys are crooks that don't pay their bills and don't answer any phone calls.

    Run as fast as you can!!!!!!!!!!

    Sentiment: Strong Sell

  • BioLargo (BLGO) and Lockheed (LMT) have proven and game changing technologies to help create abundant water for everyone.

    BioLargo’s breakthrough AOS Filter has been proven to decontaminate and disinfect water at unprecedented levels and speeds and cost 1/20th of the closest competing technology.

    The AOS Filter is showcasing this August at the University of Alberta to huge industry leaders and is extremely close to commercialization while Lockheed’s Graphene Filter is about 3 to 5 years away.

    To read report, copy and paste: Desalination Industry Screams for Cost Cutting Innovation: Lockheed And BioLargo Hold Key Technologies

    BioLargo is Strong Buy with $3.00 12-month Price Target and significantly higher prices in coming years.

    Sentiment: Strong Buy

PBF
30.61-0.96(-3.04%)Aug 3 4:03 PMEDT